# Feasibility of Doctors' Rooms-based Infusion of Zoledronic Acid

> **NCT00745485** · PHASE4 · COMPLETED · sponsor: **Novartis Pharmaceuticals** · enrollment: 186 (actual)

## Conditions studied

- Osteoporosis

## Interventions

- **DRUG:** zoledronic acid

## Key facts

- **NCT ID:** NCT00745485
- **Lead sponsor:** Novartis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-08
- **Primary completion:** 2010-07
- **Final completion:** —
- **Target enrollment:** 186 (ACTUAL)
- **Last updated:** 2017-02-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00745485

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00745485, "Feasibility of Doctors' Rooms-based Infusion of Zoledronic Acid". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00745485. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*